Duke Heart Laser study
This article was originally published in The Gray Sheet
A study of the TMR laser by Duke University's Carolyn Donovan, MD, et al., which looked at clinical outcomes for patients with end-stage coronary artery disease, showed 75% of patients improving by one angina class at 6 months post-TMR and 50% showing sustained clinical improvement at one year. The 30-patient study indicates that maximal benefit from the procedure seems to occur at 6 months but that the mechanisms for clinical improvement following TMR remain elusive. Improvement of two angina classes occurred in 17% of the patients studied at 6 months. At 12 months, one and two angina class improvement was 50% and 13% respectively
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.